BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8930210)

  • 1. Tissue distribution and complex formation with IgE of an anti-IgE antibody after intravenous administration in cynomolgus monkeys.
    Fox JA; Hotaling TE; Struble C; Ruppel J; Bates DJ; Schoenhoff MB
    J Pharmacol Exp Ther; 1996 Nov; 279(2):1000-8. PubMed ID: 8930210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group.
    Milgrom H; Fick RB; Su JQ; Reimann JD; Bush RK; Watrous ML; Metzger WJ
    N Engl J Med; 1999 Dec; 341(26):1966-73. PubMed ID: 10607813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis.
    Casale TB; Bernstein IL; Busse WW; LaForce CF; Tinkelman DG; Stoltz RR; Dockhorn RJ; Reimann J; Su JQ; Fick RB; Adelman DC
    J Allergy Clin Immunol; 1997 Jul; 100(1):110-21. PubMed ID: 9257795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen-induced seasonal allergic rhinitis.
    Adelroth E; Rak S; Haahtela T; Aasand G; Rosenhall L; Zetterstrom O; Byrne A; Champain K; Thirlwell J; Cioppa GD; Sandström T
    J Allergy Clin Immunol; 2000 Aug; 106(2):253-9. PubMed ID: 10932067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omalizumab: anti-IgE monoclonal antibody E25, E25, humanised anti-IgE MAb, IGE 025, monoclonal antibody E25, Olizumab, Xolair, rhuMAb-E25.
    BioDrugs; 2002; 16(5):380-6. PubMed ID: 12408744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of complex formation by humanized anti-IgE monoclonal antibody and monoclonal human IgE.
    Liu J; Lester P; Builder S; Shire SJ
    Biochemistry; 1995 Aug; 34(33):10474-82. PubMed ID: 7654701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical pharmacokinetics, interspecies scaling, and tissue distribution of a humanized monoclonal antibody against vascular endothelial growth factor.
    Lin YS; Nguyen C; Mendoza JL; Escandon E; Fei D; Meng YG; Modi NB
    J Pharmacol Exp Ther; 1999 Jan; 288(1):371-8. PubMed ID: 9862791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Monoclonal antibody therapy for allergic asthma].
    Nishikawa M; Matsuse T
    Nihon Rinsho; 2002 Mar; 60(3):591-7. PubMed ID: 11904978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response.
    Boulet LP; Chapman KR; Côté J; Kalra S; Bhagat R; Swystun VA; Laviolette M; Cleland LD; Deschesnes F; Su JQ; DeVault A; Fick RB; Cockcroft DW
    Am J Respir Crit Care Med; 1997 Jun; 155(6):1835-40. PubMed ID: 9196083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of allergic diseases with monoclonal anti-IgE antibody].
    Morita Y
    Nihon Rinsho; 2001 Oct; 59(10):2019-22. PubMed ID: 11676148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of human basophil IgE and FC epsilon RI alpha surface densities and mediator release by anti-IgE-infusions is reversible in vitro and in vivo.
    Saini SS; MacGlashan DW; Sterbinsky SA; Togias A; Adelman DC; Lichtenstein LM; Bochner BS
    J Immunol; 1999 May; 162(9):5624-30. PubMed ID: 10228046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-IgE as novel therapy for the treatment of asthma.
    Fick RB
    Curr Opin Pulm Med; 1999 Jan; 5(1):76-80. PubMed ID: 10813254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of allergic reactions with antibodies to IgE.
    Shields RL; Whether WR; Zioncheck K; O'Connell L; Fendly B; Presta LG; Thomas D; Saban R; Jardieu P
    Int Arch Allergy Immunol; 1995; 107(1-3):308-12. PubMed ID: 7613156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects.
    Fahy JV; Fleming HE; Wong HH; Liu JT; Su JQ; Reimann J; Fick RB; Boushey HA
    Am J Respir Crit Care Med; 1997 Jun; 155(6):1828-34. PubMed ID: 9196082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of anti-IgE in asthmatic subjects.
    Frew AJ
    Thorax; 1998 Aug; 53 Suppl 2(Suppl 2):S52-7. PubMed ID: 10193349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of cynomolgus monkey IgE to a humanized anti-human IgE antibody and human high affinity IgE receptor.
    Meng YG; Singh N; Wong WL
    Mol Immunol; 1996; 33(7-8):635-42. PubMed ID: 8760275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials results of a unique monoclonal antibody in asthma.
    Berger WE
    Allerg Immunol (Paris); 2000 Nov; 32(9):333-5. PubMed ID: 11195855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a generic immunoassay with drug tolerance to detect immune complexes in serum samples from cynomolgus monkeys after administration of human antibodies.
    Stubenrauch K; Wessels U; Essig U; Vogel R; Schleypen J
    J Pharm Biomed Anal; 2010 Jun; 52(2):249-54. PubMed ID: 20083366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human cord blood-derived mast cell responses by anti-Fc epsilon RI mAb 15/1 versus anti-IgE Omalizumab.
    Mirkina I; Schweighoffer T; Kricek F
    Immunol Lett; 2007 Apr; 109(2):120-8. PubMed ID: 17368811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-IgE therapy].
    Chazan R
    Pol Merkur Lekarski; 2003 Jun; 14(84):617-20. PubMed ID: 14524285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.